1. Osborne WR, Ochs HD. Immunodeficiency disease due to deficiency of purine nucleoside phosphorylase. In: Ochs HD, Smith CIE, Puck JM, editors. Primary immunodeficiency diseases. A molecular and genetic approach. New York: Oxford University Press; 1999. pp. 140–5.
2. Habib Dzulkarnain S, Hashim IF, Zainudeen Z, Taib F, Mohamad N, Nasir A, et al. Purine nucleoside phosphorylase deficient severe combined immunodeficiencies: a case report and systematic review (1975–2022). J Clin Immunol. 2023;43:1623-39. DOI: https://doi.org/10.1007/s10875-023-01532-5
3. Nicholas B, Svensson M, van Kuilenburg AB, Meijer J, Zoetekouw L, Truedsson L, et al. Novel genetic mutations in the first Swedish patient with purine nucleoside phosphorylase deficiency and clinical outcome after hematopoietic stem cell transplantation with HLA-matched unrelated donor. JIMD Rep. 2015;24:83-9. DOI: https://doi.org/10.1007/8904_2015_444
4. Bzowska A, Kulikowska E, Shugar D. Purine nucleoside phosphorylases: properties, functions, and clinical aspects. Pharmacol Ther. 2000;88:349–425. DOI: https://doi.org/ 10.1016/s0163-7258(00)00097-8
5. Cohen A, Gudas LJ, Ammann AJ, Staal GE, Martin DW Jr. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest. 1978;61:1405-9.. DOI: https://doi.org/10.1172/JCI109058
6. Hershfield MS, Mitchell BS. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Scriver CR, et al. eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill; 2001. p. 2585-2625
7. Papinazath T, Min W, Sujiththa S, Cohen A, Ackerley C, Roifman CM, et al. Effects of purine nucleoside phosphorylase deficiency on thymocyte development. J Allergy Clin Immunol. 2011;128:854-63.
8. Micheli V, Camici M, Tozzi MG, Pompucci G. Neurological disorders of purine and pyrimidine metabolism. Curr Top Med Chem. 2011;11:923-47. DOI: https://doi.org/10.2174/156802611795347645.
9. Markert ML, Finkel BD, McLaughlin TM, Watson TJ, Collard HR, McMahon CP, et al. Mutation in purine nucleoside phosphorylase deficiency. Hum Mutat. 1997;9:118-21. DOI: https://doi.org/10.1002/(SICI)1098-1004(1997)9:2<118::AID-HUMU3>3.0.CO;2-5
10. Walker PL, Corrigan A, Arenas M, Escuredo E, Fairbanks L, Marinaki A. Purine nucleoside phosphorylase deficiency: a mutation update. Nucleosides Nucleotides Nucleic Acids. 2011;30:1243-7. PMID: 22132981.
11. Sweetman L. Organic acid analysis in technique in diagnostic human biochemical laboratories: a laboratory manual. Hommes FA, ed. New York: Wiley-Liss; 1991. p. 143-76.
12. Chen BC, Thong MK, Yunus ZM. Biochemical profiling of inborn errors of purine and pyrimidine metabolism by high-performance liquid chromatography – a strategy to improve childhood mortality and morbidity in Malaysian children. Hamdan Med J. 2012;5:363-71. DOI: https://doi.org/10.7707/hmj.v5i3.174
13. de Azevedo WF Jr, Canduri F, dos Santos DM, Silva RG, de Oliveira JS, de Carvalho LP, et al. Crystal structure of human purine nucleoside phosphorylase at 2.3A resolution. Biochem Biophys Res Commun. 2003;308:545-52. DOI: https://doi.org/10.1016/S0006-291X(03)01464-1
14. Habib Dzulkarnain SM, Hashim IF, Zainudeen ZT, Abd Hamid IJ. Diagnostic approach and treatment of severe combined immunodeficiency. Malays J Med Health Sci. 2021;17(Supp9):176-84. DOI: https://doi.org/10.17576/MJMS.2021.1709.20
15. Giblett ER, Ammann AJ, Sandman R, Wara DW, Diamond LK. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet. 1975;1:1010-3. DOI: https://doi.org/10.1016/S0140-6736(75)91950-9
16. Ozkinay F, Pehlivan S, Onay H, van den Berg P, Vardar F, Koturoglu G, et al. Purine nucleoside phosphorylase deficiency in a patient with spastic paraplegia and recurrent infections. J Child Neurol. 2007;22:741-3. DOI: https://doi.org/10.1177/0883073807302617
17. Tasher D, Dalal I. The genetic basis of severe combined immunodeficiency and its variants. Appl Clin Genet. 2012;5:67-80. DOI: https://doi.org/10.2147/TACG.S18693
18. Felgentreff K, Perez-Becker R, Speckmann C, Schwarz K, Kalwak K, Markelj G, et al. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol. 2011;141:73-82. DOI: https://doi.org/10.1016/j.clim.2011.05.007
19. Parvaneh N, Ashrafi MR, Yeganeh M, Pouladib N, Sayarifara F, Parvaneh L . Progressive multifocal leukoencephalopathy in purine nucleoside phosphorylase deficiency. Brain Dev. 2007;29:124-6. DOI: https://doi.org/10.1016/j.braindev.2006.07.008
20. Hallett RJ, Cronin SM, Morgan G, Duley JA, Fairbanks LD, Simmonds HA. Normal uric acid concentrations in a purine nucleoside phosphorylase (PNP) deficient child presenting with severe chicken pox, possible immunodeficiency and developmental delay. Adv Exp Med Biol. 1994;370:387-9. DOI: https://doi.org/10.1007/978-1-4615-2584-4_84
21. Hirshhorn R, Canotti F. Immunodeficiency due to defects of purine metabolism. In: Ochs HD, Smith CIE, Puck JM, eds. Primary immunodeficiency diseases: a molecular and genetic approach 2nd ed. New York: Oxford University Press; 2007. P.169-96. DOI: https://doi.org/10.1093/med/9780195389838.003.0014
22. Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency diseases. J Allergy Clin Immunol. 2015;136:1186-205.e1-78. DOI: https://doi.org/10.1016/j.jaci.2015.04.049
23. Dalal I, Grunebaum F, Cohen A, Roifman CM. Two novel mutations in a purine nucleoside phosphorylase (PNP) deficient patient. Clin Genet 2001;59:430-7. DOI: https://doi.org/10.1034/j.1399-0004.2001.590608.x
24. Yeates L, Slatter MA, Gennery AR. Infusion of sibling marrow in a patient with purine nucleoside phosphorylase deficiency leads to split mixed donor chimerism and normal immunity. Front Pediatr. 2017;5:143. DOI: https://doi.org/10/3389/fped/2017/00143
25. Grunebaum E, Booth C, Cuvelier GD, Loves R, Aiuti A, Kohn DB. Updated management guidelines for adenosine deaminase deficiency. J Allergy Clin Immunol Pract. 2023;11:1665-75. DOI: https://doi.org/10.1016/j.jaip.2023.01.032
26. Giz?ewska M, Durda K, Winter T, Ostrowska I, O?tarzewski M, Klein J, et. al Newborn screening for SCID and other severe primary immunodeficiency in the Polish-German transborder area: experience from the first 14 months of collaboration. Front Immunol. 2020;11:1948. DOI: https://doi.org/10/3389/fimmu/2020/01948
27. Berger C, Trück J. Newborn screening for severe primary immunodeficiencies. Swiss Med Wkly. 2020;150:w20254. DOI: https://doi.org/10/4414/smw/2020/20254